You are viewing: Latin America AI in Oncology Market analysis
Part of: AI in Oncology Market (Global)

The Latin America AI in Oncology Market was valued at $108.2 Million in 2024 and projected to reach to $477.8 Million by 2029, representing a compound annual growth rate of 28.1%. Latin America's AI in Oncology market is poised for substantial growth, driven by increasing cancer prevalence, healthcare digitalization initiatives, and rising investments in precision medicine.

Latin America AI in Oncology Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Latin America AI in Oncology Market Trends and Insights

  • This 28.1% compound annual growth rate reflects Latin America's increasing adoption of artificial intelligence technologies in cancer diagnosis, treatment planning, and patient management.
  • Latin America is capitalizing on digital health infrastructure improvements and rising healthcare investment to integrate AI-driven oncology solutions across the region. The growth trajectory in Latin America is driven by expanding healthcare access, growing cancer prevalence, and government initiatives supporting digital transformation in oncology.
  • Latin America's healthcare systems are increasingly recognizing AI's potential to improve diagnostic accuracy and treatment outcomes while addressing resource constraints.
  • Between 2024 and 2029, Latin America is expected to emerge as a significant market for AI oncology applications, supported by partnerships between regional healthcare providers and global technology vendors..

Key Market Statistics

  • CAGR (2024-2029) 28.1% CAGR
  • Market Size, 2024 ~USD 108.2 Million
  • Forecast, 2029 ~USD 477.8 Million
  • Geography Latin America

Latin America AI in Oncology Market Overview

Rapid Market Expansion :

Latin America's AI in Oncology market is growing at 28.1% CAGR, nearly matching the global rate of 29.4%, demonstrating strong regional adoption of cancer-focused AI technologies.

Brazil Leads Regional Growth :

Brazil commands the largest market share in Latin America with $206.2 million in 2024, positioning itself as the regional hub for AI oncology innovation and investment.

Digital Health Infrastructure Development :

Latin American healthcare systems are increasingly investing in digital infrastructure, enabling seamless integration of AI-powered diagnostic and treatment planning tools across oncology centers.

Emerging Market Opportunity :

With a projected market size of $477.8 million by 2029, Latin America represents a high-growth opportunity for AI oncology vendors seeking expansion in underserved but rapidly developing markets.

Latin America AI in Oncology Market Dynamics

  • The region's 28.1% CAGR reflects growing adoption among hospitals and oncology centers seeking to improve diagnostic accuracy and treatment outcomes.
  • Government healthcare reforms and public-private partnerships are accelerating technology deployment across major markets like Brazil and Mexico. Looking ahead to 2029, Latin America will emerge as a significant growth engine for AI oncology solutions.
  • Expanding middle-class populations, improved healthcare access, and regional talent in software development will support market maturation.
  • However, regulatory harmonization, reimbursement policies, and infrastructure disparities across countries will remain key factors influencing adoption rates and market penetration across the region..

Related Ecosystem

Healthcare Analytics

Top Technologies
  • Machine Learning
  • Natural Language Processing (NLP)
  • Blood Pressure Monitors
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
Top Companies
  • Oracle Corporation
  • PHILIPS HEALTHCARE
  • Siemens healthineers
  • Zensar Technologies Limited
  • EPIC SYSTEMS CORPORATION

    Healthcare It

    Top Technologies
    • Computed Tomography (CT)
    • Machine Learning
    • Magnetic Resonance Imaging (MRI)
    • Natural Language Processing (NLP)
    • Predictive Analytics
    Top Companies
    • CERNER CORPORATION
    • PHILIPS HEALTHCARE
    • Oracle Corporation
    • GE HealthCare Technologies Inc.
    • Siemens healthineers

      Key Takeaways

      • Latin America's AI in Oncology market is valued at $108.2 million in 2024 and will reach $477.8 million by 2029, representing a 28.1% CAGR.
      • Latin America is leveraging AI technologies to address cancer diagnosis and treatment challenges across underserved healthcare systems.
      • Government digital health initiatives and increased healthcare spending are accelerating AI adoption in Latin America's oncology sector.
      • Latin America presents significant growth opportunities for AI oncology vendors through partnerships with regional healthcare institutions and public health systems.

      AI in Oncology Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment DEEP LEARNING (Type)
      Forecast Period 2024-2029
      Growth Rate CAGR of 29.4% from 2024 to 2029
      Largest Segment SOLID TUMORS (Cancer Type)
      Market Size Base Year (Billions) ~USD 2.45 (2024)
      Revenue Forecast (Billions) ~USD 8.9 (2029)
      Segments Covered Technology, Type, Application, Cancer Type, End User, Player Type, Deployment Model

      Latin America AI in Oncology Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Technology

      • Computer Vision
      • Context-Aware Processing & Computing
      • Image Analysis
      • Machine Learning
      • Natural Language Processing
      • Natural Language Processing (Nlp)

      By Type

      • Adaptive Trial Design & Monitoring
      • AI-Guided Drug Delivery
      • Brain Tumors
      • Breast Cancer
      • Candidate Selection & Validation
      • Chemotherapy
      • Clinical Trial Optimization
      • Colorectal Cancer
      • Combination & Dose Optimization
      • Computed Tomography
      • Computed Tomography (Ct)
      • Deep Learning
      • Digital Pathology & Histopathology
      • Genetic Risk Prediction
      • Hit Identification & Prioritization
      • Hit-To-Lead Identification/Lead Generation
      • Hospitals & Clinics
      • Imaging & Radiology
      • Immunotherapy
      • Intraoperative Guidance & Robotics
      • Intraoperative Guidance And Robotics
      • Laboratories & Diagnostic Centers
      • Lead Optimization
      • Leukemia
      • Liquid Biopsy & Biomarker Detection
      • Long-Term Prediction
      • Lung Cancer
      • Lymphoma
      • Magnetic Resonance Imaging (Mri)
      • Mammography
      • Mental Health & Support Systems
      • Multiple Myeloma
      • Nuclear Imaging
      • Other Healthcare Providers
      • Other Hematologic Malignancies
      • Other Hematological Malignancies
      • Other Imaging Modalities
      • Other Machine Learning Technologies
      • Other Solid Tumors
      • Other Tumors
      • Others Healthcare Providers
      • Patient Education & Empowerment
      • Personalized Treatment Planning
      • Postoperative Analysis & Recovery
      • Precision Medicine & Genomic Analysis
      • Preclinical Testing
      • Predictive Modeling For Human Trials
      • Predictive Modelling For Human Trials
      • Predictive Models For Treatment Response
      • Preoperative Imaging & 3D Modeling
      • Preoperative Imaging And 3D Modeling
      • Prostate Cancer
      • Radiation Therapy
      • Radiomics & Radiogenomics
      • Radiomics And Radiogenomics
      • Recurrence Monitoring
      • Reinforcement Learning
      • Remote Patient Monitoring
      • Specialty Centers
      • Supervised Learning
      • Surgical Planning & Assistance
      • Symptom Management & Virtual Assistance
      • Target Identification & Validation
      • Targeted Therapy
      • Treatment Recommendation Systems
      • Ultrasound
      • Unsupervised Learning
      • X-Ray Imaging

      By Application

      • Data Management & Analytics
      • Diagnosis & Early Detection
      • Drug Development
      • Drug Discovery
      • Other Applications
      • Patient Engagement & Remote Monitoring
      • Post Treatment Surveillance & Survivorship Care
      • Post-Treatment Surveillance & Survivorship Care
      • Treatment Planning & Personalization

      By Cancer Type

      • Hematologic Malignancies
      • Hematological Malignancies
      • Other Cancer Types
      • Other Cancers
      • Others Cancer Types
      • Solid Tumors

      By End User

      • Academic & Research Institutions
      • Government & Regulatory Agencies
      • Healthcare Payers
      • Healthcare Providers
      • Medical Device/ Equipment Companies
      • Medical Device/Equipment Companies
      • Other End Users
      • Pharmaceutical & Biotechnology Companies

      By Player Type

      • Business Process Service Providers
      • Integrated Suite/Platform Providers
      • Niche/Point Solution Providers
      • Technology Providers

      By Deployment Model

      • Cloud-Based Model
      • Hybrid Model
      • On-Premises Model

      Target Audience

      • AI Oncology Solution Providers : Vendors developing cancer diagnosis, treatment planning, and patient management AI solutions need Latin America market data to identify expansion opportunities and tailor offerings to regional healthcare needs.
      • Healthcare Investment Firms : Private equity and venture capital investors targeting Latin America's digital health sector require detailed market sizing and growth forecasts to evaluate investment returns in AI oncology startups and established players.
      • Hospital & Oncology Center Operators : Healthcare institutions across Latin America need market intelligence to benchmark AI adoption rates, understand competitive offerings, and make informed technology procurement decisions.
      • Medical Device & Pharma Companies : Pharmaceutical and medical device manufacturers expanding into Latin America require market data to assess AI integration opportunities in oncology workflows and identify partnership prospects.
      • Healthcare Policy & Government Bodies : Regional health ministries and regulatory agencies need market insights to develop digital health policies, reimbursement frameworks, and infrastructure investments supporting AI oncology adoption.

      Latin America vs. other regions

      HowLatin America compares to the other 3 regional blocs covered in this market.

      North America
      ~USD 4755.9 Million · 28.7% wtd CAGR ·
      Europe
      ~USD 3302.2 Million · 29.8% wtd CAGR ·
      Asia Pacific
      ~USD 2741.2 Million · 30.7% wtd CAGR ·
      Middle East & Africa
      ~USD 237.9 Million · 26.1% wtd CAGR ·

      Countries within Latin America - compare and drill down

      Country2025 size (native)
      BrazilUSD 206.2 Million
      MexicoUSD 101.1 Million
      Rest Of Latin AmericaUSD 170.5 Million

      Country market size visualization

      Brazil
      USD 206.2 Million
      Mexico
      USD 101.1 Million
      Rest Of Latin America
      USD 170.5 Million

      Reasons to Buy this Report

      • Regional Market Sizing & Forecasts : Gain precise market valuations for Latin America ($108.2M in 2024) and country-level breakdowns for Brazil, Mexico, and Rest of Latin America through 2029, enabling accurate business planning.
      • Growth Opportunity Assessment : Understand the 28.1% CAGR trajectory and identify high-potential segments within Latin American oncology AI, from diagnostic imaging to treatment planning and patient management systems.
      • Competitive Landscape Intelligence : Analyze regional market dynamics, key players, and competitive positioning specific to Latin America's unique healthcare ecosystem and regulatory environment.
      • Country-Specific Market Insights : Access detailed analysis of Brazil ($206.2M), Mexico ($101.1M), and emerging markets within Latin America to prioritize market entry and expansion strategies.
      • Strategic Investment Guidance : Leverage comprehensive market data to support investment decisions, partnership opportunities, and go-to-market strategies tailored to Latin America's oncology AI sector.

      Frequently asked questions

      What is the current market size of AI in Oncology in Latin America?

      Latin America's AI in Oncology market was valued at $108.2 million in 2024 and is projected to grow to $477.8 million by 2029.

      What is the expected growth rate for AI in Oncology in Latin America?

      Latin America's AI in Oncology market is expected to grow at a compound annual growth rate (CAGR) of 28.1% from 2024 to 2029.

      What factors are driving AI adoption in Latin America's oncology market?

      Latin America's AI oncology growth is driven by rising cancer prevalence, government digital health initiatives, expanding healthcare infrastructure, and partnerships between regional providers and global technology vendors.

      Which countries in Latin America are leading AI oncology adoption?

      Latin America's largest healthcare markets, including Brazil, Mexico, and Argentina, are leading AI oncology adoption due to advanced healthcare systems and significant investment in digital transformation.

      What challenges does Latin America face in implementing AI oncology solutions?

      Latin America faces challenges including healthcare infrastructure variability, regulatory framework development, data privacy concerns, and the need for specialized workforce training in AI oncology applications.

      RESEARCH METHODOLOGY

      The study involved significant activities to estimate the current size of the AI in oncology. Exhaustive secondary research was done to collect information on the AI in oncology market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the AI in oncology market.

      Secondary Research

      This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for the companies offering AI in oncology solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases.

      Various secondary sources were referred to in the secondary research process to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of AI in oncology vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

      Primary Research

      In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the AI in oncology market.

      After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also undertaken to identify the segmentation types, industry trends, competitive landscape of AI in oncology solutions offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies.

      In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

      Breakdown of Primary Participants:

      AI in Oncology Market

      Note 1: Others include sales managers, marketing managers, and product managers.

      Note 2: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the AI in oncology. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry and markets have been identified through extensive secondary research.
      • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
      AI in Oncology Market

      Data Triangulation

      After arriving at the overall market size using the market size estimation processes explained above, the market was split into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      AI I in oncology is the utilization of AI tools such as machine learning, natural language processing, and computer vision, among others to analyze genomic data and large gene mutations that are unique to an individual’s cancer profile. These AI tools are adopted by various end-users including labs, research centers, hospitals, and biotechnology & pharmaceuticals, among others to address the global cancer burden and the need for precision medicine in oncology.

      Further, AI boosts the speed and accuracy of cancer diagnosis and screening. The major developments include:

      • Pathologists can detect malignancy in prostate biopsy photos with the help of FDA-approved AI software.
      • AI quickly analyzes medical pictures, such as mammograms, increasing radiologists' productivity and enhancing risk assessment and detection of breast cancer.
      • Deep learning is used by NCI scientists to automatically detect precancerous cervical lesions as part of their efforts to improve cervical and prostate cancer screening.

      Stakeholders

      • Clinical/Physician Centers
      • AI Providers
      • Clinical Research Organizations
      • Pharmaceutical/Biopharmaceutical Companies
      • Research and Development (R&D) Companies
      • Business Research and Consulting Service Providers
      • Medical Research Laboratories
      • Academic Medical Centers/Universities/Hospitals
      • Government Agencies
      • Regulatory Agencies
      • Clinical Researchers
      • Clinical Research Organizations
      • Accountable Care Organizations
      • Investors and Venture Capitalists

      Report Objectives

      • To define, describe, and forecast the AI in oncology market based on player type, application, cancer type, technology, deployment model, end user, and region
      • To provide detailed information about the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
      • To analyze opportunities for stakeholders by identifying the high-growth segments of the market
      • To forecast the size of the market segments with respect to five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
      • To analyze subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market
      • To profile the key players and comprehensively analyze their market sizes and core competencies
      • To track and analyze competitive developments such as acquisitions, collaborations, agreements, mergers, product launches & updates, partnerships, expansions, and other recent developments in the market globally

      Get the Full AI in Oncology Market Report

      Full forecast, segment splits, and company analysis for all AI in Oncology Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status